What are the recommended antibiotics for treating simple pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics for Simple Pneumonia

For simple community-acquired pneumonia in adults, the first-line treatment is oral amoxicillin 3 g/day for pneumococcal pneumonia, or a macrolide (such as azithromycin) for atypical pneumonia. 1

Adult Treatment Algorithm

Outpatient Treatment (Adults)

  1. Suspected pneumococcal pneumonia (especially in adults over 40 years):

    • Amoxicillin 3 g/day orally 1
    • Duration: 7-8 days (should not exceed 8 days in responding patients) 1
  2. Suspected atypical pneumonia (adults under 40 years, within epidemic context):

    • Azithromycin 500 mg once daily for 3 days 1, 2
    • Alternative: Clarithromycin 500 mg twice daily 1
    • Duration: 3-5 days for azithromycin; 7-8 days for other macrolides 3, 4
  3. Alternative when pathogen is uncertain:

    • Respiratory fluoroquinolone (levofloxacin 750 mg daily for 5 days or moxifloxacin) 1, 5
    • Telithromycin (alternative to first-line treatments) 1

Hospitalized Patients (Non-ICU)

  • Non-antipseudomonal cephalosporin (ceftriaxone/cefotaxime) + macrolide 1
  • OR Respiratory fluoroquinolone (moxifloxacin or levofloxacin) 1
  • Duration: 7-8 days in responding patients 1

Severe Pneumonia (ICU)

  • No risk for Pseudomonas: Non-antipseudomonal cephalosporin + macrolide OR respiratory fluoroquinolone 1
  • Risk for Pseudomonas: Antipseudomonal agent (cephalosporin, acylureidopenicillin/β-lactamase inhibitor, or carbapenem) PLUS ciprofloxacin OR macrolide + aminoglycoside 1

Pediatric Treatment Algorithm

Outpatient Treatment (Children)

  1. Children < 5 years old:

    • Amoxicillin 90 mg/kg/day in 2 doses 1
    • Duration: 7-14 days 1
  2. Children ≥ 5 years old:

    • Amoxicillin 90 mg/kg/day in 2 doses (max 4 g/day) 1
    • For suspected atypical pneumonia: Add azithromycin (10 mg/kg on day 1, then 5 mg/kg/day for days 2-5) 1

Hospitalized Children

  • Fully immunized: Ampicillin or penicillin G 1
  • Not fully immunized: Ceftriaxone or cefotaxime 1
  • Add azithromycin if atypical pneumonia suspected 1

Special Considerations

Aspiration Pneumonia

  • First-line: Amoxicillin-clavulanate (1-2g PO q12h or 1.2g IV q8h) 6
  • Alternatives: Clindamycin + cephalosporin, or moxifloxacin 1, 6

Treatment Monitoring

  • Assess clinical response within 48-72 hours 1
  • Do not change treatment within first 72 hours unless clinical worsening 1
  • Consider treatment failure if no improvement after 72 hours 6
  • Measure C-reactive protein on days 1 and 3/4 to assess response 6

Switching from IV to Oral Therapy

  • Switch to oral treatment when clinically stable 1
  • Early mobilization is recommended for all patients 1
  • Low molecular weight heparin should be given to patients with acute respiratory failure 1

Important Caveats

  • Antibiotics should NOT be prescribed for acute bronchitis in healthy adults 1
  • Macrolides are preferred for atypical pneumonia due to their effectiveness against Mycoplasma, Chlamydia, and Legionella 7
  • Recent studies show shorter antibiotic courses (≤7 days) are as effective as longer courses for uncomplicated pneumonia 6
  • For penicillin-allergic patients, consider respiratory fluoroquinolones or macrolides 1
  • Resistance patterns should be considered when selecting empiric therapy, particularly for S. pneumoniae 8, 5

By following this evidence-based approach to antibiotic selection for simple pneumonia, clinicians can provide effective treatment while minimizing antibiotic resistance and adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998

Research

Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991

Guideline

Management of Suspected Bronchoaspiration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.